There is increasing evidence for familial aggregation in Parkinson's disease (PD). It is possible that some asymptomatic relatives of I'D patients have subclinical nigral Lewy body pathology and their identification could help determine the true prevalence of the disease. We used 18F-dopa positron e
β¦ LIBER β¦
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study
β Scribed by Naheed L. Khan; Enza Maria Valente; Anna Rita Bentivoglio; Nicholas W. Wood; Alberto Albanese; David J. Brooks; Paola Piccini
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 76 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Dopaminergic function in familial Parkin
β
Dr P. Piccini; P. K. Morrish; N. Turjanski; G. V. Sawle; D. J. Burn; R. A. Weeks
π
Article
π
1997
π
John Wiley and Sons
π
English
β 790 KB
Nigrostriatal dysfunction in homozygous
β
Nicola Pavese; Naheed L. Khan; Christoph Scherfler; Lisa Cohen; David J. Brooks;
π
Article
π
2009
π
John Wiley and Sons
π
English
β 156 KB
## Abstract Little is known about the rate of progression of striatal dysfunction in subjects with __parkin__βlinked parkinsonism. Being a heterozygous __parkin__ gene carrier may confer susceptibility to Parkinson's disease (PD). In a previous ^18^Fβdopa PET study, we reported that 69% of carriers
Striatal D2 dopamine receptor status in
β
Christine Dentresangle; Laurent Veyre; Didier Le Bars; Christian Pierre; Frank L
π
Article
π
1999
π
John Wiley and Sons
π
English
β 409 KB
π 1 views
Effect of partial volume correction on e
β
Olivier G. Rousset; Paul Deep; Hiroto Kuwabara; Alan C. Evans; Albert H. Gjedde;
π
Article
π
2000
π
John Wiley and Sons
π
English
β 124 KB
π 2 views